What is required when transferring controlled substances between drug outlets?

When transferring controlled substances between drug outlets, the use of a DEA 222 form is a regulatory requirement specifically for Schedule II substances. This form serves as a record of the transfer and ensures accountability and traceability of the controlled substances. It helps prevent diversion and misuse, which are major concerns with highly regulated medications.

The requirement of a DEA 222 form stems from the need for thorough documentation in the handling of these substances, as well as adherence to federal regulations governing their distribution. This procedure ensures that both the transferring and receiving outlets maintain accurate records of their inventories and comply with the Drug Enforcement Administration's regulations.

In contrast, reliance on a verbal agreement or a standard invoice without specific details does not meet the stringent documentation standards required for controlled substances, and a special notification to the FDA is not necessary for such transfers; the DEA governs these transactions.